Dialecti Voudouris, 48, a doctor who practiced in Manhattan, pled guilty August 2 to conspiracy to violate the Anti-Kickback Statute, in connection with a scheme to prescribe Subsys, a potent fentanyl-based spray, in exchange for bribes and kickbacks from Subsys’s manufacturer, Insys Therapeutics. Voudouris, a doctor specializing in oncology and hematology who worked at a private medical office on the Upper East Side, received approximately $119,400 in speaker program fees from Insys in exchange for prescribing large volumes of Subsys.
During a September 2014 dinner with several Insys executives and managers, a senior Insys executive told Voudouris, who had recently been nominated by Insys as a speaker, that he wanted her to prescribe Subsys to one new patient every day, and that Voudouris would be allocated speaker programs if she continued prescribing Subsys. In a conversation with an Insys manager and sales representative soon thereafter, Voudouris was once again informed that Insys expected her to write more Subsys prescriptions. In the months that followed the dinner and this conversation, Voudouris’s Subsys prescriptions rose significantly. By the end of the first quarter of 2015, Voudouris — who had prescribed very minimal quantities of Subsys prior to becoming a speaker for Insys — was approximately the 10th-highest prescriber of Subsys nationally, accounting for total net sales of Subsys of approximately $581,500 in that quarter alone.
